Sign in

CIK 0001512762

  • Accelerated filer
  • Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273615821
Phone
+1 650-649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 4 Shares withheld for taxes President and CEO gave up 17,867 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Financial Officer gave up 6,297 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Operating Officer gave up 6,404 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Scientific Officer gave up 5,916 shares (to pay taxes)
  6. 4/A Derivatives Options or other derivatives
  7. 3/A Insider 3/A
  8. 4/A Derivatives Options or other derivatives
  9. 3/A Insider 3/A
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Exercise or conversion Chief Financial Officer acquired 740 shares (option exercise)
  13. 4 Open-market sale Chief Medical Officer sold 1,760 shares at $18.58 ($32,699)
  14. 4 Open-market sale Director sold 25,000 shares at $20.50 ($512,500)
  15. 4 Open-market sale Chief Medical Officer sold 1,760 shares at $19.02 ($33,480)
  16. 4 Open-market sale Chief Financial Officer sold 9,291 shares at $18.56 ($172,472)
  17. 4 Open-market sale Chief Medical Officer sold 1,760 shares at an average $15.01 ($26,415)
  18. 4 Open-market sale Chief Medical Officer sold 1,760 shares at $15.00 ($26,400)
  19. 4 Open-market sale Lanfear Dennis M sold 20,984 shares at $16.26 ($341,265)
  20. 4 Derivatives Options or other derivatives

Page 12 of 20 · 399 filings